Annotation Detail

Information
Associated Genes
IGFBP2
Associated Variants
rs1996656
IGF1 c.220+4996G>T ( ENST00000337514.11, ENST00000644491.1, ENST00000392905.7, ENST00000392904.5, ENST00000307046.8, ENST00000424202.6 )
rs11111285
CCDC201 c.19-2822T>C ( ENST00000636578.2 )
IGFBP1 p.Cys230= (p.C230=) ( ENST00000275525.8, ENST00000457280.5, ENST00000468955.1 )
rs2270628
IGFBP3 p.Ala32Gly (p.A32G) ( ENST00000381083.9, ENST00000381086.9, ENST00000613132.5 )
rs2854744
rs1996656
IGF1 c.220+4996G>T ( ENST00000307046.8, ENST00000337514.11, ENST00000392904.5, ENST00000392905.7, ENST00000424202.6, ENST00000644491.1 )
rs11111285
CCDC201 c.19-2822T>C ( ENST00000636578.2 )
IGFBP1 p.Cys230= (p.C230=) ( ENST00000275525.8, ENST00000457280.5, ENST00000468955.1 )
rs2270628
IGFBP3 p.Ala32Gly (p.A32G) ( ENST00000381083.9, ENST00000381086.9, ENST00000613132.5 )
rs2854744
Associated Disease
Malignant neoplasm of ovary
Source Database
DisGeNET
Description
When evaluated individually, three SNPs in the IGFBPs (rs10228265, rs4988515 and rs2270628) were associated with increased ovarian cancer risk, and several IGF1 (rs11111285, rs1996656 and rs1019731) and IGFBP3 (rs2270628, rs2854746 and rs2854744) SNPs were significantly associated with IGF1, IGFBP3 and IGFBP2 plasma levels.
Pubmed
19858071
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00108576748832121
Year of publication
2009
Drugs